There are other course options available which may have a different vacancy status or entry requirements – view the full list of options

Make sure you check on the university, college or conservatoire website for any updates about course changes as a result of COVID-19.

Course summary

This is an exciting time to be involved in cancer therapeutics. Based upon a greater understanding of the molecular aspects of cancer, new opportunities for therapeutic intervention have emerged that are effectively 'target orientated'. These new therapeutics are quite distinct from the classical chemotherapeutic agents and they offer the prospect of truly selective cancer therapies that are tailored towards the individual patient's tumour. Cancer pharmacology plays a key role in drug development. In both the laboratory and the clinic, cancer pharmacology has had to adapt to the changing face of drug development by establishing experimental models and target orientated approaches. The programme is designed to provide you with a 'state-of-the-art' course in modern cancer pharmacology that meets the demand of employers and provides an expert view of the available cancer medicines and the development of new cancer therapies. It promotes advanced scholarship within specialised areas at the same time as the development of key transferable skills (in IT, communication, and time management) and research techniques. The taught component of the course provides the in-depth knowledge and skills necessary to work in cancer research, and is delivered across 2 semesters through lectures, workshops, practicals and 1-to-1 tutorials with ICT staff. You will then join one of our research teams to complete the MSc research project. Rankings We are ranked in the top 250 universities in the world for Pharmacy & Pharmacology in the 2019 QS World University Rankings by subject.


Entry requirements

A 2.1 Honours degree or above in a science subject; applications are welcome from candidates with non standard qualifications, with significant relevant experience. IELTS at 6.0 or the equivalent.


Fees and funding

Tuition fees

England £9230 Whole course
Northern Ireland £9230 Whole course
Scotland £9230 Whole course
Wales £9230 Whole course
Republic of Ireland £9230 Whole course
EU £23028 Whole course
International £23028 Whole course
Channel Islands £23028 Whole course

Additional fee information

No additional fees or cost information has been supplied for this course, please contact the provider directly.
Cancer Pharmacology at University of Bradford - UCAS